Molecular diagnosis of Huntington disease in Brazilian patients

Huntington disease (HD) is a progressive neurodegenerative disorder with autosomal dominant inheritance, characterized by choreiform movements and cognitive impairment. Onset of symptoms is around 40 years of age and progression to death occurs in approximately 10 to 15 years from the time of diseas...

Full description

Saved in:
Bibliographic Details
Main Authors: TEREZA C. LIMA E SILVA, HELIANE GUERRA SERRA, CARMEN S. BERTUZZO, ISCIA LOPES-CENDES
Format: Article
Language:English
Published: Thieme Revinter Publicações 2000-03-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2000000100002&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849414718531305472
author TEREZA C. LIMA E SILVA
HELIANE GUERRA SERRA
CARMEN S. BERTUZZO
ISCIA LOPES-CENDES
author_facet TEREZA C. LIMA E SILVA
HELIANE GUERRA SERRA
CARMEN S. BERTUZZO
ISCIA LOPES-CENDES
author_sort TEREZA C. LIMA E SILVA
collection DOAJ
description Huntington disease (HD) is a progressive neurodegenerative disorder with autosomal dominant inheritance, characterized by choreiform movements and cognitive impairment. Onset of symptoms is around 40 years of age and progression to death occurs in approximately 10 to 15 years from the time of disease onset. HD is associated with an unstable CAG repeat expansion at the 5' and of the IT15 gene. We have genotyped the CAG repeat in the IT15 gene in 44 Brazilian individuals (42 patients and 2 unaffected family members) belonging to 34 unrelated families thought to segregate HD. We found one expanded CAG allele in 32 individuals (76%) belonging to 25 unrelated families. In these HD patients, expanded alleles varied from 43 to 73 CAG units and normal alleles varied from 18 to 26 CAGs. A significant negative correlation between age at onset of symptoms and size of the expanded CAG allele was found (r=0.6; p=0.0001); however, the size of the expanded CAG repeat could explain only about 40% of the variability in age at onset (r2=0.4). In addition, we genotyped 25 unrelated control individuals (total of 50 alleles) and found normal CAG repeats varying from 16 to 33 units. The percentage of heterozigocity of the normal allele in the control population was 88%. In conclusion, our results showed that not all patients with the "HD" phenotype carried the expansion at the IT15 gene. Furthermore, molecular diagnosis was possible in all individuals, since no alleles of intermediate size were found. Therefore, molecular confirmation of the clinical diagnosis in HD should be sought in all suspected patients, making it possible for adequate genetic counseling.
format Article
id doaj-art-6769e24ea7ee45a29acfe59476cc0890
institution Kabale University
issn 1678-4227
language English
publishDate 2000-03-01
publisher Thieme Revinter Publicações
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj-art-6769e24ea7ee45a29acfe59476cc08902025-08-20T03:33:45ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria1678-42272000-03-01581111710.1590/S0004-282X2000000100002Molecular diagnosis of Huntington disease in Brazilian patientsTEREZA C. LIMA E SILVA0HELIANE GUERRA SERRA1CARMEN S. BERTUZZO2ISCIA LOPES-CENDES3Universidade Estadual de CampinasUniversidade Estadual de CampinasUniversidade Estadual de CampinasUniversidade Estadual de CampinasHuntington disease (HD) is a progressive neurodegenerative disorder with autosomal dominant inheritance, characterized by choreiform movements and cognitive impairment. Onset of symptoms is around 40 years of age and progression to death occurs in approximately 10 to 15 years from the time of disease onset. HD is associated with an unstable CAG repeat expansion at the 5' and of the IT15 gene. We have genotyped the CAG repeat in the IT15 gene in 44 Brazilian individuals (42 patients and 2 unaffected family members) belonging to 34 unrelated families thought to segregate HD. We found one expanded CAG allele in 32 individuals (76%) belonging to 25 unrelated families. In these HD patients, expanded alleles varied from 43 to 73 CAG units and normal alleles varied from 18 to 26 CAGs. A significant negative correlation between age at onset of symptoms and size of the expanded CAG allele was found (r=0.6; p=0.0001); however, the size of the expanded CAG repeat could explain only about 40% of the variability in age at onset (r2=0.4). In addition, we genotyped 25 unrelated control individuals (total of 50 alleles) and found normal CAG repeats varying from 16 to 33 units. The percentage of heterozigocity of the normal allele in the control population was 88%. In conclusion, our results showed that not all patients with the "HD" phenotype carried the expansion at the IT15 gene. Furthermore, molecular diagnosis was possible in all individuals, since no alleles of intermediate size were found. Therefore, molecular confirmation of the clinical diagnosis in HD should be sought in all suspected patients, making it possible for adequate genetic counseling.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2000000100002&tlng=enneurodegenerative disordersinvoluntary movementsmolecular tests
spellingShingle TEREZA C. LIMA E SILVA
HELIANE GUERRA SERRA
CARMEN S. BERTUZZO
ISCIA LOPES-CENDES
Molecular diagnosis of Huntington disease in Brazilian patients
Arquivos de Neuro-Psiquiatria
neurodegenerative disorders
involuntary movements
molecular tests
title Molecular diagnosis of Huntington disease in Brazilian patients
title_full Molecular diagnosis of Huntington disease in Brazilian patients
title_fullStr Molecular diagnosis of Huntington disease in Brazilian patients
title_full_unstemmed Molecular diagnosis of Huntington disease in Brazilian patients
title_short Molecular diagnosis of Huntington disease in Brazilian patients
title_sort molecular diagnosis of huntington disease in brazilian patients
topic neurodegenerative disorders
involuntary movements
molecular tests
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2000000100002&tlng=en
work_keys_str_mv AT terezaclimaesilva moleculardiagnosisofhuntingtondiseaseinbrazilianpatients
AT helianeguerraserra moleculardiagnosisofhuntingtondiseaseinbrazilianpatients
AT carmensbertuzzo moleculardiagnosisofhuntingtondiseaseinbrazilianpatients
AT iscialopescendes moleculardiagnosisofhuntingtondiseaseinbrazilianpatients